Open App
Company / Named in our posts

Precision BioSciences, Inc..

Follow Precision BioSciences, Inc.

Precision BioSciences is a clinical-stage gene-editing company developing therapies using its ARCUS platform.[1]

01Deal
01

Deals on Carrywatch

Every deal that names Precision BioSciences, Inc., and its role in each.

Imugene US / Precision BioSciences, Inc.

Imugene US acquires Precision BioSciences manufacturing infrastructure

See deal details
02

Deal Web

Precision BioSciences, Inc. and 0 firms it shares a posted deal with, and the path to any other firm.

03

Financials

5 fiscal years of figures as Precision BioSciences, Inc. reported them.

04

News

Loading headlines.

05

Sources

As of 24 Oct 2026.

  1. 01
  2. 02
    Form 8-K, filed August 15, 2023

    U.S. Securities and Exchange Commission · Researched 24 Oct 2026

Deal posts naming Precision BioSciences, Inc.:

  1. P01